BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 16985246)

  • 1. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
    Messina M; McCaskill-Stevens W; Lampe JW
    J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life and adult exposure to isoflavones and breast cancer risk.
    Tomar RS; Shiao R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):113-73. PubMed ID: 18569328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.
    Messina M; Hilakivi-Clarke L
    Nutr Cancer; 2009; 61(6):792-8. PubMed ID: 20155618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
    Messina MJ; Wood CE
    Nutr J; 2008 Jun; 7():17. PubMed ID: 18522734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.
    Taylor CK; Levy RM; Elliott JC; Burnett BP
    Nutr Rev; 2009 Jul; 67(7):398-415. PubMed ID: 19566600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
    Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
    Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
    Power KA; Thompson LU
    Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytoestrogens: potential benefits and implications for breast cancer survivors.
    Duffy C; Cyr M
    J Womens Health (Larchmt); 2003 Sep; 12(7):617-31. PubMed ID: 14583103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer.
    Touillaud MS; Pillow PC; Jakovljevic J; Bondy ML; Singletary SE; Li D; Chang S
    Nutr Cancer; 2005; 51(2):162-9. PubMed ID: 15860438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of dietary isoflavones for cancer.
    Andres S; Abraham K; Appel KE; Lampen A
    Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of phytoestrogen intake for breast cancer.
    Duffy C; Perez K; Partridge A
    CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary soy intake and breast cancer risk.
    Enderlin CA; Coleman EA; Stewart CB; Hakkak R
    Oncol Nurs Forum; 2009 Sep; 36(5):531-9. PubMed ID: 19726393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy intake and cancer risk: a review of the in vitro and in vivo data.
    Messina MJ; Persky V; Setchell KD; Barnes S
    Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy for breast cancer survivors: a critical review of the literature.
    Messina MJ; Loprinzi CL
    J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.
    Boucher BA; Cotterchio M; Curca IA; Kreiger N; Harris SA; Kirsh VA; Goodwin PJ
    Nutr Cancer; 2012; 64(5):695-703. PubMed ID: 22642930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety.
    Leclercq G; Jacquot Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():237-44. PubMed ID: 23274118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.